Purdue Pharma has filed a new bankruptcy plan that will distribute more than $7.4 billion to compensate opioid epidemic victims and fund addiction treatment programs. The Stamford, Connecticut-based ...
After a legal saga involving thousands of civil lawsuits, a Supreme Court ruling and what was once one of America’s wealthiest families, a U.S. bankruptcy judge has signed off on the $7.4 billion ...
A federal bankruptcy court judge on Friday said he will approve OxyContin-maker Purdue Pharma’s latest deal to settle thousands of lawsuits over the toll of opioids that includes some money for ...
Under the plan, the company will dissolve and its owners, members of the Sackler family, will pay as much as $7 billion of their personal fortune to states, localities, tribes and others harmed in the ...
STAMFORD, Conn.--(BUSINESS WIRE)--The United States Bankruptcy Court for the Southern District of New York (the “Bankruptcy Court”) today indicated it will approve the Chapter 11 Plan of ...
Purdue Pharma said Friday that the U.S. Bankruptcy Court for the Southern District of New York has indicated it intends to approve the company’s long-running Chapter 11 reorganization plan, a step ...
Purdue Pharma LP won court approval to exit bankruptcy, capping six years of legal wrangling over a multibillion-dollar settlement and liability releases for the opioid manufacturer’s Sackler family ...